RE: Great Potential3 Dec 2020 09:09
Agreed, David1951c. It's the dual-strands of the vaccine delivery AND the Oncology/Nanomerics which gives this share the potential for a major rise and then a major rise. Some way to go on the Oncology work yet as the RNS stated "The two stage programme, which is commencing immediately, is expected to take up to twelve months", but this is tremendously exciting as it doubles the rate of positive RNSs (hopefully !) and could be massively lucrative. And, you know, save lives and qualities of lives. Hopefully today's RNS establishes a new, higher level of support, attracting more investors, so the company can do its excellent work, and we can benefit financially.